Northcrest Home Health And Hospice Medicare Approved Location: 212 Northcrest Drive, Springfield, Tennessee 37172 Phone: (615) 384-9425 |
Caris Healthcare Medicare Approved Location: 2308a Memorial Blvd, Springfield, Tennessee 37172 Phone: (615) 384-3833 |
News Archive
Occupants of automobiles involved in side-impact crashes are three times more likely to suffer a traumatic brain injury than people involved in head-on or other types of collisions, according to a University of Rochester study published online for the August edition of Annals of Emergency Medicine.
Suppression of slow-wave sleep in healthy young adults significantly decreases their ability to regulate blood-sugar levels and increases the risk of type 2 diabetes, report researchers at the University of Chicago Medical Center in the "Early Edition" of the Proceedings of the National Academy of Science, available online as soon as Dec. 31, 2007.
Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced today that the US Food and Drug Administration (FDA) has accepted its Extended Release Carbinoxamine Oral Suspension NDA for the treatment of allergies in kids two years and older. If approved, Tris Pharma's Extended Release Suspension will provide an alternative to the currently available immediate release formulations.
Astellas Pharma Inc. and Ambit Biosciences Corporation announced today that the results from a completed Phase 2 study with the investigational FLT3 inhibitor, quizartinib (AC220), as an oral monotherapy treatment regimen in patients with relapsed or refractory acute myeloid leukemia (AML) were presented at the 54th Annual Meeting of the American Society of Hematology (ASH).
› Verified 3 days ago